DOAC
Showing 1 - 25 of 167
4-Factor PCC in DOAC-associated Intracranial Hemorrhage
Recruiting
- Intracranial Hemorrhage
- Use of fixed-dosed 4F-PCC
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Atrial Fibrillation Trial in United States (AFSW Guided DOAC, Continuous DOAC therapy)
Not yet recruiting
- Atrial Fibrillation
- AFSW Guided DOAC
- Continuous DOAC therapy
- (no location specified)
Apr 19, 2023
Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])
Not yet recruiting
- Liver Cirrhosis
- Apixaban 5 MG [Eliquis]
- Edoxaban 60 MG [Lixiana]
- (no location specified)
May 19, 2023
Determining Clinical Relevance of Interaction Between
Recruiting
- Drug-drug Interaction
- Blood sampling - Pharmacokinetic assessment
-
Nijmegen, Netherlands
- +2 more
Oct 26, 2022
Ischemic Stroke, Atrial Fibrillation Trial (Left atrial appendage Occlusion and 3 months of Clopidogrel, DOAC)
Not yet recruiting
- Ischemic Stroke
- Atrial Fibrillation
- Left atrial appendage Occlusion and 3 months of Clopidogrel
- DOAC
- (no location specified)
Jul 27, 2023
Venous Thrombosis, Tumors, Anticoagulants Trial in Kyoto (Long DOAC, Short DOAC)
Recruiting
- Venous Thrombosis
- +2 more
- Long DOAC
- Short DOAC
-
Kyoto, JapanDepartment of Cardiovascular Medicine, Kyoto University Graduate
Mar 29, 2022
DOAC in Chinese Patients With Atrial Fibrillation
Recruiting
- Atrial Fibrillation
- +6 more
- Blood Tests
-
Hong Kong, Hong KongChinese University of Hong Kong
Oct 11, 2022
Bleeding Post Cardiac Surgery, Indication for Anticoagulation Trial in Hamilton (DOAC, VKA)
Recruiting
- Bleeding Post Cardiac Surgery
- Indication for Anticoagulation
- DOAC
- VKA
-
Hamilton, Ontario, CanadaHamilton General Hospital
Oct 31, 2022
GastroIntestinal Bleeding, Anticoagulant-induced Bleeding Trial in Ottawa (Restart DOAC within 7 days of clinical hemostasis
Not yet recruiting
- GastroIntestinal Bleeding
- Anticoagulant-induced Bleeding
- Restart DOAC within 7 days of clinical hemostasis after GI bleeding
- Restart DOAC between 7 to 14 days of clinical hemostasis after GI bleeding
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Mar 21, 2022
Atrial Fibrillation, Coronary Artery Disease, Anticoagulants Trial (Uninterrupted NOAC use, Interrupted NOAC use)
Not yet recruiting
- Atrial Fibrillation
- +2 more
- Uninterrupted NOAC use
- Interrupted NOAC use
- (no location specified)
Jul 20, 2021
Baseline Concentration of Direct Oral Anticoagulant and
Recruiting
- Atrial Fibrillation
- Anticoagulant-induced Bleeding
-
Cremona, ItalySophie Testa
Jul 19, 2022
Mild Head Injury, Antiplatelets, and Anticoagulants
Completed
- Craniocerebral Trauma
- Cerebral Hemorrhage
- direct anticoagulant
- +2 more
-
Roma, Rm, ItalyFondazione Policlinico Universitario Agostino Gemelli - IRCCS
Mar 29, 2022
Cancer Associated Thrombosis for Rivaroxaban - United States
Completed
- Treatment of Venous Thromboembolism in Cancer Patients
- Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Multiple Locations, ConnecticutMany Locations
May 18, 2022
Association Between Genetic Variant Scores and DOACs (DARES2)
Recruiting
- Drug-Related Side Effects and Adverse Reactions
- Iatrogenic Disorder
-
Seongnam-si, Gyonggi-do, Korea, Republic ofSNUBH
Jul 18, 2022
Venous Thromboembolism Trial in France (Reduced dose of DOAC, Full dose of DOAC)
Recruiting
- Venous Thromboembolism
- Reduced dose of DOAC
- Full dose of DOAC
-
Amiens, France
- +38 more
Apr 21, 2022
Percutaneous Coronary Intervention (PCI), Atrial Fibrillation (AF), Oral Anticoagulation Trial in Worldwide (P2Y12 inhibitor,
Not yet recruiting
- Percutaneous Coronary Intervention (PCI)
- +3 more
- P2Y12 inhibitor
- +2 more
-
Hasselt, Belgium
- +13 more
Jul 25, 2023
DOAC ADRs Retrospective Study
Terminated
- Drug-Related Side Effects and Adverse Reactions
-
San Jose, CaliforniaSanta Clara Valley Medical Center
Mar 4, 2021
Anticoagulant-induced Bleeding Trial in Quebec (Warfarin, Dabigatran, Rivaroxaban)
Not yet recruiting
- Anticoagulant-induced Bleeding
- Warfarin
- +4 more
-
Quebec, CanadaInstitut Universitaire de Cardiologie et de Pneumologie de Quebe
Feb 17, 2021
Ventricular Tachycardia, Premature Ventricular Contraction, Stroke Trial in India, United States (DOAC, Aspirin)
Specific PoC Testing of Coagulation in Patients Treated With
Recruiting
- Anticoagulation With NOAC
- anti-Xa activity point-of-care testing (aXa-POCT)
- ecarin clotting time point-of-care testing (ECT-POCT)
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Dec 14, 2020
Classification Study for the TEG 6S System
Completed
- DOAC Eligible Subjects
- TEG6s DOAC Cartridge
-
South Bend, Indiana
- +3 more
Feb 10, 2020
Splanchnic Vein Thrombosis, Cerebral Vein Thrombosis, Ovarian Vein Thrombosis Trial in Varese (Direct Oral Anticoagulants)
Unknown status
- Splanchnic Vein Thrombosis
- +4 more
- Direct Oral Anticoagulants
-
Varese, ItalyUniversity of Insubria
Apr 30, 2020
Atrial Fibrillation Trial in Hamilton (PAUSE Perioperative DOAC Management, ASRA Perioperative DOAC Management)
Unknown status
- Atrial Fibrillation
- PAUSE Perioperative DOAC Management
- ASRA Perioperative DOAC Management
-
Hamilton, Ontario, Canada
- +2 more
Jan 20, 2020
Interference Between Oral Anticoagulants and Heparin During
Recruiting
- Atrial Fibrillation
- Atrial Tachycardia
-
Paris, FranceHopital Bichat-Claude Bernard
Mar 27, 2023
Anticoagulant Therapy Trial in Mannheim (Apixaban 5 MG Tab, Dabigatran 150 MG Tab, Edoxaban 60Mg Tab)
Active, not recruiting
- Anticoagulant Therapy
- Apixaban 5 MG Tab
- +3 more
-
Mannheim, GermanyClincial Research Serivces
Aug 4, 2022